MNOV
Price
$1.45
Change
-$0.02 (-1.36%)
Updated
Mar 28, 6:59 PM EST
43 days until earnings call
PTN
Price
$1.84
Change
+$0.25 (+15.72%)
Updated
Mar 28, 6:59 PM EST
46 days until earnings call
Ad is loading...

Compare trend and price MNOV vs PTN

Header iconMNOV vs PTN Comparison
Open Charts MNOV vs PTNBanner chart's image
Medicinova
Price$1.45
Change-$0.02 (-1.36%)
Volume$41.16K
CapitalizationN/A
Palatin Technologies
Price$1.84
Change+$0.25 (+15.72%)
Volume$149.26K
CapitalizationN/A
View a ticker or compare two or three
MNOV vs PTN Comparison Chart

Loading...

MNOVDaily Signal changed days agoGain/Loss if shorted
 
Show more...
PTNDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
MNOV vs. PTN commentary
Mar 29, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MNOV is a Hold and PTN is a Hold.

COMPARISON
Comparison
Mar 29, 2024
Stock price -- (MNOV: $1.45 vs. PTN: $1.87)
Brand notoriety: MNOV and PTN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MNOV: 99% vs. PTN: 69%
Market capitalization -- MNOV: $71.12M vs. PTN: $30.18M
MNOV [@Biotechnology] is valued at $71.12M. PTN’s [@Biotechnology] market capitalization is $30.18M. The market cap for tickers in the [@Biotechnology] industry ranges from $570.99B to $0. The average market capitalization across the [@Biotechnology] industry is $2.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MNOV’s FA Score shows that 0 FA rating(s) are green whilePTN’s FA Score has 0 green FA rating(s).

  • MNOV’s FA Score: 0 green, 5 red.
  • PTN’s FA Score: 0 green, 5 red.
According to our system of comparison, MNOV is a better buy in the long-term than PTN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MNOV’s TA Score shows that 6 TA indicator(s) are bullish while PTN’s TA Score has 5 bullish TA indicator(s).

  • MNOV’s TA Score: 6 bullish, 3 bearish.
  • PTN’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, MNOV is a better buy in the short-term than PTN.

Price Growth

MNOV (@Biotechnology) experienced а +2.11% price change this week, while PTN (@Biotechnology) price change was +15.43% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.98%. For the same industry, the average monthly price growth was +8.91%, and the average quarterly price growth was +90.55%.

Reported Earning Dates

MNOV is expected to report earnings on May 10, 2024.

PTN is expected to report earnings on May 14, 2024.

Industries' Descriptions

@Biotechnology (+4.98% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for MNOV with price predictions.
OPEN
A.I.dvisor published
a Summary for PTN with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
MNOV($71.1M) has a higher market cap than PTN($30.2M). MNOV YTD gains are higher at: -3.333 vs. PTN (-53.015). MNOV has higher annual earnings (EBITDA): -9.88M vs. PTN (-34.7M). MNOV has more cash in the bank: 51M vs. PTN (9.49M). MNOV has less debt than PTN: MNOV (216K) vs PTN (821K). PTN has higher revenues than MNOV: PTN (7.1M) vs MNOV (1M).
MNOVPTNMNOV / PTN
Capitalization71.1M30.2M235%
EBITDA-9.88M-34.7M28%
Gain YTD-3.333-53.0156%
P/E RatioN/AN/A-
Revenue1M7.1M14%
Total Cash51M9.49M538%
Total Debt216K821K26%
FUNDAMENTALS RATINGS
MNOV vs PTN: Fundamental Ratings
MNOV
PTN
OUTLOOK RATING
1..100
1852
VALUATION
overvalued / fair valued / undervalued
1..100
40
Fair valued
96
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
94100
PRICE GROWTH RATING
1..100
6165
P/E GROWTH RATING
1..100
10093
SEASONALITY SCORE
1..100
9550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MNOV's Valuation (40) in the Biotechnology industry is somewhat better than the same rating for PTN (96). This means that MNOV’s stock grew somewhat faster than PTN’s over the last 12 months.

MNOV's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as PTN (100). This means that MNOV’s stock grew similarly to PTN’s over the last 12 months.

MNOV's SMR Rating (94) in the Biotechnology industry is in the same range as PTN (100). This means that MNOV’s stock grew similarly to PTN’s over the last 12 months.

MNOV's Price Growth Rating (61) in the Biotechnology industry is in the same range as PTN (65). This means that MNOV’s stock grew similarly to PTN’s over the last 12 months.

PTN's P/E Growth Rating (93) in the Biotechnology industry is in the same range as MNOV (100). This means that PTN’s stock grew similarly to MNOV’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MNOVPTN
RSI
ODDS (%)
Bullish Trend 2 days ago
62%
Bullish Trend 1 day ago
77%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
84%
Bullish Trend 1 day ago
81%
Momentum
ODDS (%)
Bullish Trend 1 day ago
71%
Bullish Trend 1 day ago
78%
MACD
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
77%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
70%
Bullish Trend 1 day ago
78%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
70%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 8 days ago
70%
Bullish Trend 8 days ago
77%
Declines
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 4 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
89%
Aroon
ODDS (%)
Bullish Trend 1 day ago
68%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
MNOVDaily Signal changed days agoGain/Loss if shorted
 
Show more...
PTNDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LEN171.983.48
+2.07%
Lennar Corp
QUAD5.310.04
+0.76%
QUAD/GRAPHICS
AGRO11.020.07
+0.64%
Adecoagro SA
FIVN62.10-0.20
-0.32%
Five9
GETR0.31N/A
-0.84%
Getaround